The primary active ingredient in Lipodissolve is phosphatidylcholine, a naturally occurring compound sourced from soybeans. Upon injection into targeted adipose tissue, phosphatidylcholine induces fat cell lysis, facilitating the release of their contents. The body's metabolic processes subsequently eliminate the liberated lipids via the lymphatic system.
Lipodissolve necessitates multiple sessions, with intervals of several weeks between each. The requisite number of sessions depends on individual factors and the area under treatment. Outcomes generally manifest after two to four sessions, and treated regions continue to exhibit improvement as the body expels the lysed fat cells.